Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Post transfusionnal iron overload].

Christian Rose1

  • 1Service d'onco-hématologie, université catholique de Lille, hôpital Saint-Vincent-de-Paul, 59020 Lille Cedex. rose.christian@ghicl.net

La Revue Du Praticien
|April 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ambient AI Scribes and Emergency Department Documentation Burden: Retrospective Cohort Study.

JMIR AI·2026
Same author

Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence.

Breast (Edinburgh, Scotland)·2026
Same author

AI counseling agent for motivational interviewing: Conversational processes associated with change talk in emergency department patients.

Journal of substance use and addiction treatment·2026
Same author

SCALES-AI: A Supervision- and Context-Aligned Entrustment Framework for Integrating Artificial Intelligence Into Emergency Medicine Education.

AEM education and training·2026
Same author

Predicting Future Organ Support Needs Using Longitudinal Emergency Department Data: A Proof-of-Concept Study.

Research square·2026
Same author

ED-Explain: Personalized Video Instructions for Patients Discharged from the Emergency Department.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Post-transfusion iron overload, common in thalassemia, causes serious health issues. Newer oral iron chelators like deferiprone and deferasirox offer effective, less burdensome alternatives to traditional therapy.

Area of Science:

  • Hematology
  • Pharmacology
  • Internal Medicine

Background:

  • Post-transfusion iron overload is a significant complication in patients requiring frequent red blood cell (RBC) transfusions, such as those with thalassemia.
  • This iron accumulation leads to severe morbidity and mortality, particularly cardiac dysfunction.
  • Current iron chelation therapy aims to mitigate these risks.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of oral iron chelators (deferiprone and deferasirox) as alternatives to deferoxamine (DFO) for managing iron overload.
  • To assess the impact of these newer chelators on cardiac outcomes.

Main Methods:

  • Comparative trials assessing iron burden reduction.
  • Evaluation of patient compliance and tolerability.

Related Experiment Videos

  • Analysis of cardiac outcomes in patients receiving different chelation therapies.

    • Main Results:

    • Oral chelators deferiprone and deferasirox were effective in reducing iron levels, comparable to DFO.
    • Deferasirox demonstrated good tolerability, while deferiprone was associated with improved cardiac outcomes.
    • Newer oral agents offer a less burdensome treatment option compared to DFO.

    Conclusions:

    • Oral iron chelators represent a promising advancement in managing iron overload, offering improved compliance and comparable efficacy to DFO.
    • While effective, long-term follow-up data are still needed to fully establish the benefits of these newer agents over traditional methods.